Table 4.
Rank | Locus number^ | Gene | Product | Product size (aa) | Structural druggability* | Essential | Choke-point | Network centrality | Presence in pathogenic Kp (%) | Pathways involved# | DrugBank Inhibitor& |
---|---|---|---|---|---|---|---|---|---|---|---|
1 | 02296 | argA | Amino-acid acetyltransferase | 443 | 0.75 | Yes | Yes | 0.89 | 100 | L-ornithine [B], L-arginine [B] | ND |
2 | 01032 | fabB | 3-oxoacyl-[acyl-carrier-protein] synthase 1 | 407 | 0.74 | Yes | Yes | 0.64 | 100 | Biotin [B], Fatty acids [B] | Approved (DB01034) |
3 | 00796 | pssA | CDP-diacylglycerol–serine O-phosphatidyltransferase | 451 | 0.86 | Yes | Yes | 0.06 | 97 | Phosphatidylethanolamine [B] | ND |
4 | 01800 | lpxD | UDP-3-O-[3-hydroxymyristoyl] glucosamine N-acyltransferase | 341 | 0.82 | Yes | Yes | 0.07 | 100 | Lipopolysaccharide [B] | ND |
5 | 01909 | murF | UDP-N-acetylmuramoyl-tripeptide–D-alanyl-D-alanine ligase | 452 | 0.76 | Yes | Yes | 0.08 | 100 | Peptidoglycan [B] | Experimental (DB06970) |
6 | 01907 | murD | UDP-N-acetylmuramoylalanine–D-glutamate ligase | 438 | 0.71 | Yes | Yes | 0.02 | 100 | Peptidoglycan [B] | Experimental (DB03801) |
7 | 01797 | lpxB | Lipid-A-disaccharide synthase | 383 | 0.92 | Yes | Yes | 0.06 | 100 | Lipopolysaccharide [B] | ND |
8 | 05359 | trpA | Tryptophan synthase alpha chain | 270 | 0.63 | Yes | Yes | 0.52 | 100 | L-tryptophan [B] | ND |
9 | 00662 | asd | Aspartate-semialdehyde dehydrogenase | 368 | 0.58 | Yes | Yes | 0.05 | 100 | L-lysine [B], L-threonine [B], L-methionine [B], L-homoserine [B] | Experimental (DB03502) |
10 | 01899 | lpxC | UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase | 306 | 0.78 | Yes | Yes | 0.29 | 100 | Lipopolysaccharide [B] | Experimental (DB07861) |
11 | 04194 | lpxK | Tetraacyldisaccharide 4′-kinase | 326 | 0.69 | Yes | Yes | 0 | 100 | Lipopolysaccharide [B] | ND |
12 | 01905 | murG | undecaprenyl-PP-MurNAc-pentapeptide-UDPGlcNAc GlcNAc transferase | 356 | 0.8 | Yes | Yes | 0.06 | 100 | Peptidoglycan [B] | Murgocil (ref.106) |
13 | 31828 | murE | UDP-N-acetylmuramoyl-L-alanyl-D-glutamate–2,6-diaminopimelate ligase | 495 | 0.85 | Yes | Yes | 0.03 | 97 | Peptidoglycan [B] | Experimental (DB03801) |
14 | 05226 | hpxT | 5-hydroxyisourate hydrolase | 109 | 0.6 | Yes | Yes | 0.007 | 100 | Purine metabolism | ND |
15 | 03831 | dapE | Succinyl-diaminopimelate desuccinylase | 375 | 0.81 | Yes | Yes | 0.08 | 100 | L-lysine [B] | ND |
^The K. pneumoniae Kp13 locus suffix ‘KP13_’ is omitted; *druggability of the protein considering the highest scoring pocket. #B: biosynthesis. &Data gathered from http://www.drugbank.ca for orthologs of each protein with relevance studied on a per-target basis. ND, not determined.